163 related articles for article (PubMed ID: 17786539)
1. Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells.
Dallas NA; Fan F; Gray MJ; Van Buren G; Lim SJ; Xia L; Ellis LM
Cancer Metastasis Rev; 2007 Dec; 26(3-4):433-41. PubMed ID: 17786539
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
3. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
5. EGFR/VEGF signalling pathway in colorectal cancer: the way we are!
Spano JP; Milano G; Baselga J
Bull Cancer; 2005 Aug; 92(Spec no):S3-4. PubMed ID: 16387661
[No Abstract] [Full Text] [Related]
6. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
7. Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Hyder SM
Endocr Relat Cancer; 2006 Sep; 13(3):667-87. PubMed ID: 16954424
[TBL] [Abstract][Full Text] [Related]
8. The vascular endothelial growth factor family and its receptors.
Parikh AA; Ellis LM
Hematol Oncol Clin North Am; 2004 Oct; 18(5):951-71, vii. PubMed ID: 15474329
[TBL] [Abstract][Full Text] [Related]
9. Current insights on the biology and clinical aspects of VEGF regulation.
Birk DM; Barbato J; Mureebe L; Chaer RA
Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic therapy against gastrointestinal tract cancers.
Iwasaki J; Nihira S
Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
[TBL] [Abstract][Full Text] [Related]
11. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
[TBL] [Abstract][Full Text] [Related]
13. Tumour-associated angiogenesis in human colorectal cancer.
Rmali KA; Puntis MC; Jiang WG
Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
[TBL] [Abstract][Full Text] [Related]
14. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor.
Ferrara N
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):789-91. PubMed ID: 19164810
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor angiogenesis.
Gaur P; Bose D; Samuel S; Ellis LM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
[TBL] [Abstract][Full Text] [Related]
17. VEGF and myeloid leukemias.
Frankel AE; Gill PS
Leuk Res; 2004 Jul; 28(7):675-7. PubMed ID: 15158088
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
20. VEGF-targeted therapy: mechanisms of anti-tumour activity.
Ellis LM; Hicklin DJ
Nat Rev Cancer; 2008 Aug; 8(8):579-91. PubMed ID: 18596824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
